Chemoprevention of prostate cancer
- 30 April 2005
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 54 (1) , 1-10
- https://doi.org/10.1016/j.critrevonc.2004.11.008
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCERJournal of Urology, 2004
- Selenium: Epidemiology and Basic ScienceJournal of Urology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Prevention of Prostate Cancer with Finasteride: US/European PerspectiveEuropean Urology, 2003
- Dutasteride, the dual 5α–reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell lineThe Prostate, 2003
- Time Trends and Characteristics of Men Choosing Watchful Waiting for Initial Treatment of Localized Prostate Cancer: Results From CaPSUREJournal of Urology, 2003
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Serum selenium and risk of prostate cancer in U.S. blacks and whitesInternational Journal of Cancer, 2002
- Health Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: Results From the Prostate Cancer Outcomes StudyJNCI Journal of the National Cancer Institute, 2000
- Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate CancerJAMA, 2000